he signed a contract with merck once merck decide which made in the cells that would have been worth up to $1 million to him personally had it been executed by shortly after he signed it nih heard and got wind that he was selling a cell and sent out chief investigate of frud and abuse and call shriver to investigate. he resign ised under pressure from stanford an spent many years in the -- in weld witherness and can put it so accurately when he said that he became public this really is a great tragedy this is a man who at the height of his powers brought about his own down fall. that's front phage of "the new york times" on a sunday in march of 1967 where one of the headlines says -- nih investigator by the united states -- he spent many years redealing his reputation if you talk to anyone today what they will know about is the limit. very important discovery of cellar mortality. they will not be aware probably of his really difficult interval in mid-1970s. and also won't be aware of the tremendous contribution he made to getting safe, mini cellar factories into circulation for makin

he signed a contract with merck, once merck decided to switch to plotkin's rubella vaccine, that would be worth one million dollars to him personally had it been executed. shortly after he signed it, the nih heard and got wind he wasd selling the cells and sent out the chief investigator of waste, fraud and abuse, a no-nonsense guy james shriver to investigate.e. he resigned under pressure from stanford and spent many years in the academic wilderness. i think his colleague stan plotkin really put it so accurately when he said the science, hayflick went to public, this is brokerage youre did i. this man who at height of his powers brought about his own downfall. that is the front page of "new york times" on march of 1976 where one of headlines says,. [ih says investigators, investigator sold cells owned by the united states. hayflick spent many years redeeming his reputation. if you talk to anyone today what they will know about is the hayflick limit, very important discovery of cellular mortality. they will not be aair probably of his really difficult interval in the mid-1970s. they al

rival merck saw its profit top expectations. the drug maker raised its full year revenue and earnings forecast and said a key cancer drug is gaining market share. as you might expect, shares of pfizer and merck moved in opposite directions. >>> a weak month for auto sales also weighed on the market today as americans didn't buy cars in april at the pace they had been. general motors saw a nearly 6% drop in monthly sales. fiat-chrysler a bit more than that. ford sales down more than 7%. declines could signal that demand is slowing after seven straight years of sales growth. automakers are also offering more deals so that they don't lose sales in the very hot suv market. increased incentives is a concern for investors. and they sold shares off today of the automakers in trading. >>> from driving to flying. after a stream of incidents where airline crews had altercations with passengers, congress called industry leaders up to capitol hill, including the ceo of united continental. lawmakers today asked them why flying in america has

we will be speaking with merck's cfo. u.k.uxury retailer burberry reported earnings that surpassed analyst estimates to make cost cuts and improving trends in china. adjusted pretax profit was 400 62 .4 million pounds, the average analyst addictions. the incoming ceo will be speaking -- seeking to grab a larger share of the high-end market in july as global demand recovers. investment by china's largest internet company and blockbusters in gaming is thing off. tencent posted record quarterly sales and profit topping all estimates. as titles such as honor of king's trophy users to spend on naming. strategy is transforming tencent into a hybrid marvel studios-netflix company. that is your bloomberg business flash. matt: thanks ray a much. i am standing outside the shareholders meeting. the focus is going to be on two things. can the bank continue its strategy after the 180 degree flip-flop we had from them a couple of months ago, that strategy to reintegrate postbank there asset management units in order to raise more capital. t

at big round of names reports before the bell, including conoco phillips, mastercard, merck and pfizerafter the bell the mother of all earnings reports, apple. on the economic front. the fed kicks off its two-day policy meeting. the big automakers will release april auto sales. >>> indian outsourcing firm infosys is making a big bet on america. the company announcing it will create 10,000 jobs here in the united states of the next two years. those jobs will focus on the cloud, artificial intelligence and big data. four new facility also open as well. with the next one by summer, august of 2017. i'll speak with the indiana governor and the infosys ceo today at 8:00 a.m. eastern on a cnbc exclusive. it will be interesting to see this broader trend, international companies feeling the pressure from president trump and showing they are willing to invest in america's job story. >>> stocks to watch today, barry dillers will buy angie's list and create a publicly traded company called angie home services. up 41%. advanced micro devices matching estimates in the latest quarter but shares dropp

. >> reporter: the biggest companies in the space are merck, bristol-myers squibb, astrazeneca, roche, and pfizer. the companies have generated results that have excited the medical community. it was merck's keytruda that former president jimmy carter credited with completely shrinking the brain tumors associated with his stage iv melanoma. not all patients see such a dramatic benefit. so a key strategy is combination therapy, finding out if putting multiple drugs together produces responses. >> some patients don't respond or don't respond for very long. we're really trying to understand more to the next level. >> reporter: these research updates frequently move stocks as drug makers compete. >> investors are putting anywhere between 30 and $40 billion, and investors are trying to figure out how you divvy that up. >> reporter: insight's shares spiked after an experimental drug showed promising results in combination studies in a number of different cancer sites. with combination therapy looking like the future of cancer treatment, another question arises -- cost. with many of the newe

and also reporting, pharmaceutical giants pfizer and merck.a few of their patents are about to expire while merck has a cancer drug that is considered to be the most significant growth driver for the company. interesting, so a lot to talk about in the united states, samira hussein will be on the case when it comes to apple etc. joining us is kathleen brook, research director for city index. it isa it is a busy time with apple earnings and bp etc. one thing we wa nted earnings and bp etc. one thing we wanted to talk about was greece, coming through in the early hours of the morning that finally a deal on new measures and new reforms meaning they get much—needed funding. new measures and new reforms meaning they get much-needed funding. this has been going on for absolutely yea rs. has been going on for absolutely years. they are trying to extend the pension age. make people older before they receive their pension, trying to sell off state assets, coal mines, power plants and that kind of thing. this still needs to be agreed by the greek governm

thank you very much. >>> merck gets treated for key true dah.or the interview but let's get more on this. >> key true dah is one of the drugs next to chemotherapy. jimmy carterer has stage four melanoma he credited key true dah for shrinking the tuesday his or her. the drug was expanded to a broader set of patient in accordance with chemotherapy. there'll be projected 220,000 cases of cancer this year and more of deaths from the disease. the drug issing with many others. analyst estimate the drug will drive $4 million this year. ken frazier the ceo of merck joining us to tell us what does this mean for patients? >> thanks meg for having me. i think this is an important step for patient but it's important to rmgz it's one step on the journey where we're going to be able to provide therapies for big patients going forward. >> tell us the next step for the drug? you're continuing to test with lunge cancer what are some of the next big cast list we see here? >> if you take a step back we're studding this drug by 30 tumor types, so for us it's all ab

starting with merck.erck came out with numbers that beat expectations on the bottom and top lines. earnings are an adjusted 88 cents a share. street was looking for 83 cents a share. sales of $9.3 billion, versus 9.2 billion expectations. some of the sales lines looking through, remicade down. animal health sales were up by 13%. the guidance that the company now saying it's even adjusted number of $3.76 to $3.88 a share. street was at $3.81. so the high end is a little bit higher than had been anticipated before. but again that stock right now looks like it was up by about 2%. now we should take a look at pfizer numbers. pfizer did beat on the bottom line. 69 cents versus 67 cents the street was looking for. the revenue line was just a little bit lighter than had been expected. $12.8 billion versus the $13 billion the street was anticipating. pfizer saying it sees earnings of $2.50 to $2.60 for the full year. the street's estimates right in the middle of that at $2.55. >> okay. we are going to change topi

>> merck pharmaceutical. >> i like merck, but it's slow and steady wins the race.ersey. raja. >> caller: good evening cramer and thanks for taking my call. can you hear me? >> yes, yes. >> caller: thank you for everything you do for callers like me, wooirm calling about exact sciences. >> what can i say? it's for real, when i say for real, it just moved up 5 straight bucks. anywhere pull back i like it because it's a game changer, ladies and gentlemen, the conclusion of "the lightning round." what's with the dog-size? i'm crazy stressed trying to figure out this complex trade so i brought in my comfort pony, warren, to help me deal. isn't that right warren? well, you could get support from thinkorswim's in-app chat. it lets you chat and share your screen directly with a live person right from the app, so you don't need a comfort pony. oh, so what about my motivational meerkat? in-app chat on thinkorswim. only at td ameritrade. >>> there's nothing like a thesis that keeps paying off through thick and thin and up and down. one that's able to with stand everything fro

tenemos de hoy >>> tenemos de todo luis carlos hoy, felicidad, y un noticia que debe penar a los a merckl segundo tiempo gracias a una magnÍfica de carlos orrantia que concretÓ paco torres, universitarios y camoteros estÁn por supuesto fuera de la fiesta grande. fecha 36 en la liga premier de inglaterra el arsenal derrotÓ 2 a 0 al manchester united con goles del suizo y welbeck liquidando la racha de 6 meses en condiciÓn que tenÍa el equipo de mourinho y alcanzar final cuando el prÓximo jueves reciba al celta de vigo. hablemos de boxeo, mucho ruido y pocas nueces fue lo ocurrido anoche en las vegas en el promocionado combate, sin ningÚn tÍtulo en disputa, un espectÁculo para ser taquilla y vender el pago r evento sin ningÚn tipo de proyecciÓn deportiva, canelo fue superior se llevÓ la decision unÁnime, los 3 jueces lo vieron ganar todos los 12 asaltos. al fin al final de la pelea, apareciÓ el ruso para retar entre comillas al canelo esto estaba negociado y se enfrentan el prÓximo 16 de septiembre aprovechando quÉ raro la celebraciÓn del dÍa de la independencia de mÉxico, una pelea espera

this is been a year that has been pivotal for merck.he health care unit has made steps forward with its first new drug in more than a decade. it was clear to's sale in the u.s. or quickly than expected. that's where the focus will be. may put itssaid it three divisions into subsidiaries. we will keep and i'll these numbers coming through and will be speaking to the management of this company a little bit later on coming up today in programming on bloomberg. they see full-year net sales of 50.5 going to 16 billion. their are sticking to gut. let's look at the list that we run here in bloomberg. the risk off sentiment grip the market yesterday. wall street finally woke up to the political risk. the question is, is it pricing in impeachment, or just a long, bumpy road. at amazon loss $1.7 billion. in total, are rich list at bloomberg demolished, $35 billion of their wealth. does it marked the end of the so-called trump rally, rather than the type of plunge that -- list with the risk radar up. we can see that little bit .3% on the s&p at th

drugs, big driver sales growth with the one-year chart of merck.o, we are hearing from pfizer, the drugmaker decided not to split itself up last year or so watching for word on a possible deal to fill out visors product pipeline. a more volatile chart as you can see for pfizer, the one here as well. apple of course centerstage. apple to deliver the best answer sales growth. a lot of that based on iphone sales. a big report coming out today as well. dagen: absolutely, cheryl. we usually look at ge. try apple. thank you so much, cheryl. president trump said to speak with vladimir putin. in the meantime, angela merkel paying a rare visit to russia. what it means for relations with the country. and it was all about wearing weird clothing at night, -- matt galli. however he just can it be? you will see that turned out it's at the star-studded event. straightahead. ♪ why pause a spontaneous moment? cialis for daily use treats ed and the urinary symptoms of bph. tell your doctor about your medicines, and ask if your heart is healthy enough for sex. do not

. >>> one of merck's key medicine received approval from the fda last night to treat advanced lung cancer in combination with other chemotherapies. the drug is already approved to treat other types of cancer. the company's ceo says he's seeing positive results. >> we're studying keytruda in almost 500 clinical trials. that's unprecedented. we're studying it across 30 tumor types. we're encouraged by data that we see in 20 tumor types. for us, it's all about making sure that we do the right studies, both mono therapy and in combination, to make the drug broadly available for patients who need it. >> shares rose marginally to $64.63. >>> the gun and ammo company vista outdoor reported a decline in sales and profits, saying it experienced an unprecedented drop in demand for its weapons and other products following donald trump's presidential victory. vista outdoor also gave full year guidance that was below street forecast but said it expects that excess inventory caused by the demand drop to stabilize, and that comment gave investors hope that the slump in gun sales may be nearing an end an

as we reported, apple reports earnings along with fellow dow components pfizer and merck. auto sales for april will be released. and on capitol hill, the ceo of united continental will testify in front of a house panel over the recent removal of a passenger from a recent flight. >>> sue, more than half of americans either own or work for a small busi. according to the small business administration, they create about two out of every three new jobs in the united states every year. a growing number of small businesses are started by millennials, but this group is facing some challenges. as part of our small business week series, kate rogers traveled to atlanta. >> reporter: like many millennials, 29-year-old candace mitchell graduated from georgia tech with student debt. but that wouldn't stop her from pursuing her passion. >> rather than seeing it as a weakness, i saw it more as an opportunity to really be even more courageous when it comes to making sure that i am successful. >> reporter: in 2014, mitchell decided to start her own business. >> my ivana specifically recomme

this is france, merck on redefining the relationship between france and germany.he details on what has been going on in wall street. two bits of economic news, the consumer price index and retail sales. economists estimate that the cbi will increase by 0.2% in april after a fall of 0.3% in march. it seems it may be the same story for sales, the expectation is they will be up by 0.6% after falling by 0.2% in expectation is they will be up by 0.6% afterfalling by 0.2% in march. speaking of retail salesjcpenney will be reporting earnings. the company is looking to cut costs as sales continue to slide. they said backin sales continue to slide. they said back in february they would close 130-140 back in february they would close 130—140 underperforming stores over the next few months and they will offer volu nta ry the next few months and they will offer voluntary retirement for about 6000 employees. joining us is nandini ramakrishnan, global market strategist atjp morgan asset management. yesterday we had the bank of england giving their inflation report and their inf

there will be fairly large areas of cloud floating around that a lot of cloud, miffed and merck in ther spells, there could be apache frost to take us into the morning. tomorrow, another quiet day. there will be differences in the detail. in the north—east quite a lot of cloud and the odd spot of drizzle. the best of sunshine the south and west. eastern areas will be on the cool side. in the south and west we will have the highest temperatures. that is where we will see most of the sunshine. it will be quite cloudy at lord's for the cricket tomorrow for england against ireland. as we go into the start of the new week, eastern areas will often be rather cloudy. the cloud could be big enough to produce the odd spot of drizzle. in the west more in the way of sunshine. for all of us are slightly cooler feel to the weather. things are quiet on the face of it. there are some ups and downs and differences in the detail was you can keep up to date with the latest details for where you are by logging onto the website. this is bbc news at two. the headlines... theresa may has been campaigning in

. >> -- merck tesse, president of stan understand university and dr. rick lifton, the president of -- the united states is atop the list of global investors in lifesons, this investment is dependent on the nih and the important research it funds in order to maintain ore international leadership in pie bee medicine we mist strengthen the partnerships ben government agencies, investos, academies and research foundations. this meeting was an important step. today shortly after this briefing we'll release a list of the president's thirdwave of forward court nominees these ten individuals were chosen to a deep 'knowledge of the law and commit upholdinges constitutional principles. if confirmed justice joan larson will be a circuit court judge of the u.s. court of appeal for the six inch circuit. justice larson is currently serving on the michigan supreme court. and justice david stroud will be a circuit court judge of the u.s. court of appeals for the eight inch circuit. es current i is a justice of the minnesota supreme court. the campaign list which was p

pfizer and merck before the open. on the performance, one of the company's newer cancer drugs and its biggest driver of sales growth. nicole: coming up, vice president mike pence makes a late night visit to capitol hill for the health care bill. we will have the latest vote count. and how will the housing market they are under a trump presidency? we will take a closer look at that. you are watching "fbn:am," your first look at morning markets and breaking news. ♪ .. nicole: rise and shine. let's get you caught up on what is happening. the white house has armed to vote on a rise health care plan. vice president mike pence visiting capitol hill yesterday to drum up support from revealing about my care. officials tell fox business they believe they are only a handful of votes from getting the bill passed in the house and the vote could happen as soon as tomorrow. president trump scheduled to speak with russian president latin america newton today for the first time since relations between washington and moscow are at an

. >>> the fda has approved merck's drug to treat cancer in adults and children who carry specific geneticits. the drug was previously approved to treat head and neck companieses. >>> shares of universal health services are lower on reports that the fbi launched probes into the hospital operator. buzzfeed is looking into whether the hospital kept patients for as long as insurance would cover them rather than medical need. >>> a new york state appeals court has ruled common mobile mu exxonmobil must turn over records about how long it knew about global warning. again, no real move in exxon share prices. >>> when we come back, we're talking grains and grain alcohol. two big m&a stories developing overnight. we'll tell you the details when we return. >>> first a look at european markets this morning. the ftse 100 slightly higher. france and germany slightly lower. back on "worldwide exchange" in a couple minutes. since i added futures, i have access to the oil markets and gold markets. okay. i'm plugged into equities- trade confirmed- and i have global access 24/7. meaning i can do what i nee

some questions that i will submit for the record and that said it is my great privilege today for merck chief counsel who is president trump's nominee for the antitrust division with the extensive background the president could not affect a more qualified nominee with more than 40 years of experience on this committee i have for closely with some of those mines in the nation but among them during those several years serving as my chief counsel and committee staff director as a trusted confidante. he executed the duties and to this day one of the most talented chief counsels have ever hired. the white house took notice of his talents and in 2003 president bush asked him to serve as the deputy assistant attorney general with the justice department and having already served as deputy assistant attorney general he is exceptionally well qualified to serve today. to serve as a member of the task force on intellectual property to be the point person on the antitrust issues. also led that appellate litigation and during his tenure at the department of justice he played key roles with the agency

the s&p 500 reporting, the two big names to watch, conocophillips, merck, apple, facebook, tesla, kelloggnd cvc. >>> fred chairman ben bernanke joins "squawk box" for an hour an exclusive here from 8:00 to 9:00 eastern today. s his thoughts on the president and the economy. and the future. that's on "squawk box," 8:00 a.m. >>> still to come here on "worldwide exchange," of the second round of the french election less than a week away. we'll tell you what global investors need to be watching within that. you're watching "worldwide exchange" here on cnbc. thanks for loading, sweetie. ...oh, burnt-on gravy? ...gotta rinse that. nope. no way. nada. really? dish issues? throw it all in. new cascade platinum powers through... even burnt-on gravy. nice. cascade. if you want to stay on top of your health, one simple thing to do -- is take the pledge to go and get screened for the cancers that might affect you. so stand up to cancer and take the pledge at getscreenednow.org it only takes a minute to take care of yourself, and nothing rhymes with "org"... >>> let's get back out to washington, d.c.

merck. >> it's okay. it's been all right. >> a lot of stocks are kind of stalled. to see some takeovers. >> it's a tuesday but it's another week -- we have seen a low level of m&a activity in terms of big head leans. >> like to see china doing better for datter pi caterpilla. >> if that continues you will take a summer break. >> yeah, i will, listen, july and august, let's go to the beach, let twitter dangle here for a little. twitter was doing good. time for jack dorsey to say i've won in square. he got me as a customer for caviar. >> consolidating. >> jack you got me as a customer, sarah fryer can run it, step down. she's a fabulous cfo out of goldman and devote full time to twitter that, stock goes to 2, i just gave him as re recipe. >> did you it. >> jack sometimes watches we'll see if he responds. >> he's not like john ledger. >> we'll get with jim in a moment. later on exclusive with leon kuku cooperman of omega advisers. think again. ork? this is the new new york. we are building new airports all across the state. new roads and bridges. new mass transit. new

coca-cola on interactive experiences such as combining coke bottle answers spotify and merck invested di, personal dna testing, 23 and me and general motors investing in lyft. now of disruptor, banks are the most active. jpmorgan chase and 7 followed by american express with four investments. microsoft is next with three investments. this is part of an overall surge of corporate venture capital. since 2013 there are more than 5,000 corporate deals and more than $100 billion invested in startups by corporate vcs, according to pitch book. while they have their total r & d arms there is something about the innovative ideas of startups that is hard to recreate internally. you can find out more about the big trend on cnbc.com. melissa? >> thank you so much. julia boorstin. pe have about three hours until the "closing bell" here. stocks are higher across the board. on track for the best day for the month of may. our final trades, next. the power of innovative thinking. the power of 100 of the world's top companies. the power of an etf. the power of qqq. the thinking we put in, clients get o

bristol myers, merck, roche and as kra senne kai, however, people are looking at a new player, incytestock could swing 10 to 15% on either direction on how the experimental drug how that data looks, so people will be watching that closely. people are also looking at eli lily and nectar in the spaces, another area. looking at companies like juno, bluebird and kite. a lot of these stocks are the ones that move, but companies aross the board presenting data tonight. >> thank you so much. kevin, are you buying anything in this space? >> i also go golong going goo ts data set. i'm always going going into this and every year, we seem to get an acceleration on new uther pis. t hard to pick stoms. it is good news for the indices and this year, we've got exciting stuff. j&j is a perennial hold iing fo me. tonight is a big deal because it takes about a month to go through this stuff and let the analysts tell you what's going to happen. >> i like bristol myers and celgene. i don't have a huge exposure to bio tech. after meg's reporting this morning and tomorrow and people breaking it down over t

merck beating on profit and sales, boosting outlook. look at april auto sales. this is tough. journal headline, hot streak rapidly cooling for u.s. auto sales, especially for detroit companies. gm and ford sales. gm down 5.%. ford off more than 7%. toyota only automaker benefited. problem, weak demand for trucks and suvs. that led to big record levels since the bailout back in 2009. back to you guys. david: ford under 11 bucks a share. unbelievable. melissa. melissa: big names driving nasdaq into record territory. todd horowitz from bubba trading.com, james freeman from the "wall street journal." james, are these records in technology making you nervous? you do you he think there is more room here? are they justified? what is your take? >> you can't say stocks are cheap right now. melissa: no. >> look at historical levels with earnings relative to price. this is a great earnings season. we still have very low interest you rate environment. we think of the fed gradually tightening, probably not this week. right now low interest rates, potential of good news that helps companies

that puts more pressure on merck kel. creating a straw man in president trump is beneficial to angela merkel right now. it brings the country together. it is us versus him. that is very convenient for her. david: climate change is another one of those issues they're looking for a straw man. president trump is reportedly whether to announce he will pull out of the so-called paris accord on climate change. john tamney hoping he will announce our exit from the accord. he wrote a terrific piece about this in real clear markets. you can look at it online. why, john, why should we withdraw from it? >> we should withdraw from it because it is economy-sapping concept where we allow the glal treatto reduce normal market operationof the marketplace. the other thing, why on earth would trump enter into any treaty by europeans or pressure on them. if you look at nato, they have not lived up to the pledges to fund nato. the u.s. basically funded that, the majority of that to its economic detriment. look at trades europeans enter among

even come -- it's so far above bigger pharmaceutical company executive comp saying like pfizer and merckthey don't get anywhere near that. >> there's no doubt. they were getting huge payouts over this time and now they're going to have to deal with it. and we know this is front and center, and they've had to roll this back because there are really no other choices for the most part for this type of medication that's needed. and so the united states that's paying for it for schools, for hospitals and of course -- liz: required. >> right. required. and also for individuals as well. liz: nicole petallides from the floor of the new york stock exchange. we're watching mylan stock, and we should also say -- what are we at now, acia? 25 requests or so into mylan to have the ceo come on. they will not. we'll have more on this story tomorrow because new york city controller scott stringer has been outraged about all of this. he's going to explain why the nyc pension fund is going after mylan's board and lining their pockets with all of that money. closing bell ringing in 26 minutes. they're buzzi

>> sean: you changing your political views question merck >> i'm coming out tonight as a conservativesed you so much. >> sean: welcome back. you disappeared for a while. i'm not getting involved. we're glad to have you back, good to see you both. we appreciate you being here. liberals, if you are true to your belief system, freedom of speech, free and open exchange of ideas and ideals and opinions, you've got to start standing up for conservatives. people will go after you too. when we come back, isis-related arrests, suicide bombings on the rise. katherine harris has a full report a very disturbing reports tonight will get reaction from colonel oliver north and a may day protests turned into a riot in portland, oregon, . wait till you see molotov cocktails and rocks thrown at police. david limbaugh and jay sekulow, straight ahead. when dad forgot how to brush his teeth. (woman vo) in march, my husband didn't recognize our grandson. (woman 2 vo) that's when moderate alzheimer's made me a caregiver. (avo) if their alzheimer's is getting worse, ask about once-a-day namzaric. namzaric is

as we await the big earnings, take a look at the dow, barely in the green as chevron, exxon, merck. apple reporting disappointing iphone sales yesterday. the dow had been in the red all morning. that changed at about 2:00 p.m. when the federal reserve announced it would hold off a rate hike until the economy really started to grow more. financials climbing though as investors do seem to be betting on the slow growth being short-lived. melissa. melissa: breaking earnings. facebook set to release first quarter results any minute. investors keeping a close eye on user growth and video ads as the tech giant tries to curb recent scrutiny on handling of live video content on live screen. we shanna glenze-r, make offices chief marketing officer. fox business's hillary vaughn. jonathan what you do you expect? >> i expect higher prices for facebook. melissa, one of the reasons why, is an element you just alluded to, hiring of 3,000, essentially monitors for some of the content on facebook. that is one of the reasons they're making news. the fact they're so quick to address it is emblematic w

bristol-myers and merck had big updates on their drugs.owever they're not really moving that much this morning or in the after hours last night. as we may get more updates at the meeting. they were testing two drugs in come flags wibination with a dr insight, a next generation way of using immunotherapy. trying to test these combinations in different cancers and see if we can get better response rates and see if more patients willbinations of . >> what wave are we in, in broad strokes what do you think this conference will signify? >> it's all been sort of a progression. over the last few years, we've been introduced to immunotherapy. companies are trying to figure out how to put the drugs together to get more people to respond to them, so have more people fight their cancer better. they're figuring that out now. we had merck on last week, saying they have 500 clinical tries now in massive studies. they got approved for something else. >> nonsmall cell lung cancer. exciting, but mid stage innings probably. >> meg, thanks. >>> we will get b

david: merck and among the dow's biggest drags. we have breaking news on unprecedented global cyberattack. we heard a little abt it from melissa. it is now affecting fedex and microsoft in a big way. ashley webster with details from the new york stock exchange. ashley, this could change fortunes of some companies. ashley: certainly could, david. massive attack in europe and asia. 12 countries at last count. you mentioned individual companies. fedex certainly one of those affecting. they say their windows-based system has been interfered with. they're not say you how widespread the problem is whether it is impacting deliveries. they say they will deal with it as quickly as possible. microsoft has responded customers who are running their free anti-virus software have their windows updates enabled are completely protected. apparently not everyone had that. they are working with those companies who are still dealing with this malware situation. wells fargo, you remember the whole story about the bogus bank accounts and credit card acc

merck getting a boost after one of its drugs was added -- got approval to be added for diagnosedfor newlyrs. exxon mobil raising, along with the price of oil. if you look at what has happened this year, you have had a switch. the s&p 500 growth index is an white. the s&p is the basement in yellow. the s&p value index is in blue. a lot of this has to do with technology in the app performance that group. julia: thanks. scarlet: let's get to one of the most widely read stories on the bloomberg u.s. prosecutors investigating one of wall street 's darkest markets, scrutinizing hedge funds that allegedly solicited bogus bond price quotes from brokers. isning us from san francisco matt robinson, a financial fund reporter. did us a sense of what we know about the extent of this probe. how wide ranging is it? are there big names? matt: the probe is looking at a lot of structured credit hedge funds that invest in illiquid bonds that rarely trade. there is a lot of wiggle room that hedge funds have in trying to figure out there valuation. they can go to some friendly brokers who can turn back prices

higher profit at merck and raised its forecast, a huge drug company. nice move, 1.2% higher.izer helped by better sales of the cancer drug and-- profits down at cvs. it felled fewer prescriptions and lower traffic. that hurt sale of front end store items. the stock is up 5 cents at 82. what's the price gasoline, by the way? 2.37 that's regular. and now president trump sauce he'd consider raising the gas tax. liz: the problem, in new jersey and across the country, you can't have a lock box towards infrastructure. it goes toward things as bicycle path, horse trails or lan scaping on the highway. it's going to be tough for the president to do something like this. they go insane at the pump when see see it go up. stuart: scott, you're in london where it's $10 a gallon. that's right, you don't want to smoke or drive here. you would consider breaking up the banks, consider-- he's a business man, he'll consider everything, whether it's a good idea or a bad yiet, he wasn't taken that off the table and said that while running. he'll consider them until they take them off the double. w

they'll look at merck and say why are you pulling out when business big companies like exxon is backing in the world? >> well, it's not just abdicating leadership. it's actually going unilateral and pulling yourself out when other countries, the big polluters, countries, particularly important, china, actually signed up. so why storm out of the tent? we don't get it. >> and india as well, one of the great polluter. idea that climate change is a u.s. threat to national security. >> climate change is still disputed among scientists but unbalanced. given the risk, you might say why take the risk of not remember, more than 20 years ago george bush refused to sign the kyoto accord. again, that accord did not include china. and skoonld, the senate was massively against more than 95 votes. this is not the case today. this was a big consensus behind paris. >> has this enhanced china's leadership? >> well, if you put it on top of the trans-pacific partnership which again president trump pulled out of, that again seeds ground to china and that's going to worry a lot of people. not just in europe

merck has report that a vaccine approved by china's drug administration. you are also seeing some weakness coming through from by moreirport a cut cory on friday. -- by mcquarrie on friday. optimism driven by financials and energy players. betty: another stock we are watching, shares of takata. the automakers settlement, the biggest rise in four months, a settlement worth 553 million dollars to resolve the economic loss claims tied to the company's faulty products, tour yoda, subaru, mazda, reimbursing out-of-pocket asked insist come a providing loners and setting up an outreach program to increase participation in recalls. thatan see by how much stock has risen given the clarity. let's stay in japan and talk about softbank and masayoshi son , formally announcing the first round of capital commitment for its tech investment fund worth more than $93 billion. asia managing editor for technology in tokyo, one of the richest men in the world, when you open a fund come you will get billions of dollars, so who is income of who is not in, and what is next year? s

merck approved use of therapy in combination with chemotherapy to treat lung cancer.ock up a fraction. that's a story we've been following for quite a while now. >> yeah. one of the leaders in the dow today. the treasury secretary is in germany, and he's there with a mission, and cnbc's ylan is traveling with him. what's he looking to accomplish, ylan? >> reporter: kelly, one of the big fears among officials here is the united states might implement a border adjustment tax raising cost of foreign goods, but a treasury official told me today that a border adjusted tax in the current form does not work. that is some of the strongest language we've heard out of the treasury department on this issue, and it should be a relief to officials here as they convene for the g7 finance minister's meeting, but it does not solve the bigger frustrations that many countries have over u.s. companies, particularly in the tech sector, shifting profits to low tax jurisdictions. italy has been one of the countries that's been cracking down on this issue. they settled with google recently

one of those drugs is not even legal in the united states, an anti-inflammatory that merck did not getroval for here in the united states. obviously it's quite a cocktail if they're all taken together so i hope if he needs help he gets that help. what do you think tiger woods needsstates. what do you think tiger woods need to do now patrick? >> well, obviously there's got to be tremendous recommendation of his image and sports psychologist. i'm sure he's reached out to someone of that elk before but we can only put ourselves in that place. if i was revered as one of the greatest athletes at all times, which he was at one point, if i was making the kind of money i was making, to see it decline as it has, he's likely to lose another $15 million from endorsement that's depressing. he needs to reach out and seek help to get him over these thing. certainly on top of that is a prk r surgery is required as well. >> pr surgery that's an interesting term. in terms of the standpoint of the sponsors can they get a deal at this point then? >> i think from a brand perspective i don't think they're

. >> the only one doing better is merck which had good news on chemo. >> a humble man, he'll be on laterfantastic work. i think the stock should be up more because this will be a $9 billion drug in five years. it's a remarkable drug. it keeps solving all the different forms. never want to get ahead of yourself because people have cancer, you never want to hear on tv that this is a cure all. but these are very good results. remember, this is -- everything that goes up there is bad for bristol-myers. bad. >> finally, macy's, got below 26 in the premarket. hasn't been below there in the regular session in six years. >> rather amazing. >> almost six years. >> it's just rather -- i mean, they don't have it. meanwhile, kohl's is finally getting the respect it deserves. it's up for the day. there's differentiation in retail. that's what starting to happen. it's not all losers. >> and macy's is going to take along with it nordstrom. ralph. coors is down today. simon property and ggp, a couple of the mall names we mentioned a few moments ago. >> we have to get some time with macy's to get them to

merck says profit will be little changed after faster than expected u.s.pproval for a new cancer drug. earnings-per-share will be between 6.15 euro. hargreaves lansdown reported assets rose 10% to 77 billion pounds. the u.k. asset manager also said chairman mike evans plans to step down once a successor is identified. on tuesday 8.5% after vanguard said it would start a u.k. online service. been so, brazil has plunged back into political crisis after reports that michel temer was involved in a cover-up scheme with the jailed speaker of the lower house of congress.. derail thes this reforms that temer is eagerly trying to push through? justin: well, it certainly threatens them, mark, because the market has been very favorable towards temer, seeing him as the man u has been driving this effort to push through the i pension reforms tot considered so important get the country fiscal house in order. athis is the first stage of something that can turn very ugly but it is early days. what you're likely to see is when the markets open in brazil, a little bit of a

this is obama deal that has no upside for the united states of merck at all.trump unfortunately in a position where he can't let down what is considered one of america's most key allies. and so he has got to reluctantly honor this deal. but i think there is going to be quite a frosty element to this meeting coming up in new york. charles: by the same token their positions echo the fact they both have some extreme concerns about these refugees he flee these countries and terrorists being embedded among them and burden on host country. >> definitely, charles, it is important to remember, i don't want to get too detailed bit, really malcolm turnbull had no choice because his predecessor he stole the job from is the person that did the work on securing australia's borders making sure illegal immigration wasn't such a problem. he kind of kept that going because it was so popular. in that sense there is some symbiosis. the truth i don't think malcolm turnbull, i think malcolm turnbull is much more open borders guy. charles: really? i didn't know that the headlines i

merck leading the charge for the dow and as you said, saw earlier, record high on the nasdaq. modi is on the floor. >> positive open for wall street with the nasdaq hitting another all-time high. earnings stealing the spotlight continuing the discussion jim was just saying. s&p 500 companies that generate more than half of their revenue overseas are posting quarterly earnings growth of nearly 20%, that's double that of companies that conduct most of their business domestically, data according to facts the less u.s. companies exposed to america the better its results. now let's talk about earnings, surprisingly strong quarter for british petroleum, net profit nearly tripled from a year earli earlier. bp's positive quarter behind the rebound in oil prices today and sticking with energy, the largest u.s. exploration company cono conocophillips reporting a rebound in profits as it steps up its drilling onshore and shares down 1.4%. check out shares of infosys big bet on the u.s. plans to hire 10,000 u.s. workers over the next two years, its biggest expansion in the west in an effo

the department of homeland security plays a pivotal role in keeping merck americans safe by working to combat terrorism, manage our air, land, sea borders, administer our laws, secure cyber assets and prepare for and respond to disasters. the tragic events in manchester, england, earlier this week remind us why we must focus on the serious challenge of securing our homeland. mr. secretary, you've dedicated your career into serving ourg national interests and in just a few months you've proven your ability to lead the department during a val challenging time. this subcommittee will work to support you and the men and women of the department who are working every day to keep us safe. the department is being called on by this president to refocus its resources on certain national security risks and redouble efforts 10 to force our immigration laws. we look forward to learning more about how the department proposes to address these needs while ensuring we do not neglect the other critical missions of the department. this budget request gets many things right, we've seen over the past few m

mark -- merck's drugs have risen. it is gaining ins rates against bristol-myers squibb.stimates. net debt rose again. bps stock has been the worst performer this year alone oil companies. alix: apple is the markets top billionr adding 120 dollars in value since the election. shares are at a record high. for more on what to expect from the company's earnings we are joined by shawn harrison. talk to me about what happens when you have a earnings for a company where everybody loves to get in and trading at a record high. there's an expectation very short-term that it's waiting for the next super cycle along with another big cash return announcement. it is still at a discount to the s&p ahead of what could be a very robust cycle for the iphone in the coming months and quarter. in the meantime you might have to deal with some softer q3 guidance of iphone sales. what kind of risk is there shorter-term for the stock? against very easy you will see the iphone 7 plus becoming more and more popular. in the very short-term expectations are muted. growth will be relatively muted. lo